TinyGemsBreaks Archive - Page 11 of 133

TuesdayJun 03, 2025 9:50 am

TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Relaunches FIVE RS EV for German Market with FPF Partnership

Mullen Automotive (NASDAQ: MULN) announced the relaunch of its ultra-high-performance Mullen FIVE RS EV Crossover, with vehicle sales targeted to begin in Germany by December 2025. Following successful 800V battery testing at TUV SUD in Munich, the vehicle is entering on-road validation as part of its final homologation process. Mullen has partnered with Germany-based Faissner Petermeier Fahrzeugtechnik AG (FPF), a veteran automotive engineering and manufacturing firm, to ensure production meets the highest global standards. The FIVE RS boasts a top speed of 200 mph, 0–60 acceleration under two seconds, and over 1,100 horsepower. Mullen plans to expand sales across the EU,…

MondayJun 02, 2025 11:15 am

TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) Increases Ownership of Bollinger Motors to 95%, Resolves Receivership

Mullen Automotive (NASDAQ: MULN) has acquired an additional 21% stake in Bollinger Motors, bringing its total ownership to 95% and increasing shareholder equity by approximately $3.5 million. The move follows Mullen’s resolution of outstanding claims and debt that had placed Bollinger under court-ordered receivership, a case now dismissed with prejudice. Bollinger will continue operating independently under Mullen’s ownership, with its commercial EV lineup—led by the all-electric B4 Chassis Cab—receiving full support for sales, service, and warranty. Mullen plans to leverage synergies to accelerate the B4’s development and drive growth within the commercial EV space. To view the full press release, visit…

ThursdayMay 29, 2025 9:20 am

TinyGemsBreaks – Mullen Automotive Inc. (NASDAQ: MULN) to Implement 1-for-100 Reverse Stock Split on June 2

Mullen Automotive (NASDAQ: MULN) announced it will enact a 1-for-100 reverse stock split effective June 2, 2025, aiming to regain compliance with Nasdaq’s $1.00 minimum bid price requirement. Approved by shareholders on May 21 and finalized by the board, the reverse split will reduce Mullen’s outstanding common shares from approximately 80 million to about 800,000, with trading to begin on a split-adjusted basis under the same ticker symbol. No fractional shares will be issued, and all existing equity instruments and convertible securities will be proportionally adjusted, excluding the 2022 Equity Incentive Plan, which remains unchanged. To view the full press release,…

TuesdayMay 27, 2025 11:36 am

TinyGemsBreaks – NextPlat Corp. (NASDAQ: NXPL) Announces Passing of CEO Charles M. Fernandez, Appoints Interim Leadership

NextPlat (NASDAQ: NXPL, NXPLW) announced with deep sadness the sudden passing of Executive Chairman and CEO Charles M. Fernandez on May 24. Fernandez had led the company since July 2021. The Board has appointed Rodney Barreto, Chair of the Audit Committee, as Interim Chairman, and David Phipps, current President and CEO of Global Operations, as Interim CEO. Vice Chairman Doug Ellenoff expressed condolences, noting Fernandez’s dedication to family and the company. Barreto, a director since 2022, brings over 35 years of business and civic leadership, while Phipps previously led NextPlat through its early growth and Nasdaq listing. The company is…

TuesdayMay 27, 2025 10:16 am

TinyGemsBreaks – SolarBank Corp. (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) Advances 6.9 MW Community Solar Project in Nova Scotia

Disseminated on behalf of SolarBank Corporation SolarBank (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2) will develop the 6.9 MW DC Brooklyn solar project in Nova Scotia under Canada’s first Community Solar Program. Owned by AI Renewable Fund, the $13.9 million project will be built in partnership with local firm Trimac Engineering. The program supports Nova Scotia’s goal of reaching 80% renewable energy by 2030 and net-zero by 2035. SolarBank will oversee interconnection, permitting, and design through 2025, with construction expected to begin in spring 2026. The company also disclosed a shares-for-services agreement with an independent advisor valued at up to…

ThursdayMay 22, 2025 3:11 pm

TinyGemsBreaks – Calidi Biotherapeutics Inc.’s (NYSE American: CLDI) RTNova Shows Promise in Targeted Tumor Therapy

Calidi Biotherapeutics (NYSE American: CLDI) recently announced promising preclinical results for its RTNova platform, a breakthrough in the delivery of transient gene therapy payloads to targeted tumors. The innovative platform not only targets cancer cells effectively but also minimizes harm to surrounding healthy tissues, potentially improving treatment outcomes and reducing side effects. As global cancer rates continue to rise, Calidi’s RTNova platform and tumor-specific virotherapy hold the promise of offering new hope to cancer patients, addressing the limitations of existing treatments, and potentially improving survival rates across multiple cancer types. The company’s ongoing research and deep commitment to scientific excellence position…

TuesdayMay 20, 2025 9:20 am

TinyGemsBreaks – NextPlat Corp (NASDAQ: NXPL) Named Exclusive UK and EEA Distributor for ZOLEO Satellite Devices

NextPlat (NASDAQ: NXPL, NXPLW) announced that its subsidiary, Global Telesat Communications Ltd (GTC), has been appointed the exclusive distributor for ZOLEO Inc. across the UK and European Economic Area. ZOLEO's flagship global satellite communicator extends smartphone messaging coverage via the Iridium(R) satellite network and has earned accolades including Outdoor Retailer’s Innovation Award "Product of the Year." The partnership adds to GTC’s expanding e-commerce and Amazon storefront portfolio of satellite connectivity solutions for remote workers, outdoor enthusiasts, and global travelers. To view the full press release, visit: https://ibn.fm/soHab About NextPlat Corp NextPlat is a global e-commerce platform company created to capitalize…

MondayMay 19, 2025 9:00 am

TinyGemsBreaks – SolarBank Corp. (NASDAQ: SUUN) (CSE: SUNN) Reports Q3 Results; Eyes Long-Term Gains with $100M Project Financing

Disseminated on behalf of SolarBank Corporation SolarBank (NASDAQ: SUUN) (CSE: SUNN) posted fiscal Q3 results for the period ended March 31, 2025, showing year-to-date revenue of C$29.1 million versus C$50.4 million a year earlier, reflecting a shift toward long-term asset ownership over short-term EPC sales. The company reported a net loss of C$9 million compared to net income of C$5.5 million last year, driven by higher costs and reduced EPC activity. SolarBank highlighted a 395% increase in assets to C$194 million following the Solar Flow-Through Funds acquisition and secured a mandate letter with CIM Group for up to US$100 million…

FridayMay 16, 2025 2:20 pm

TinyGemsBreaks – Capstone Holding Corp. (NASDAQ: CAPS) Reaffirms 2025 Guidance, Highlights M&A Pipeline and Flexible Growth Strategy

Capstone Holding (NASDAQ: CAPS)  reaffirmed its 2025 targets of a $100 million revenue run-rate and $10 million in adjusted EBITDA, supported by a strong M&A pipeline and disciplined cost control. The company is evaluating acquisition opportunities at 4–6x EBITDA multiples, with up to 45% non-cash consideration, and has secured an equity line of credit to support deals without upfront dilution. Subsidiary Instone remained on track despite seasonal headwinds, with cost run-rate guidance intact and growth expected to pick up in Q3. To view the full press release, visit https://ibn.fm/kwEhl About Capstone Holding Corp. Capstone Holding Corp. (NASDAQ: CAPS) is a…

FridayMay 16, 2025 11:28 am

TinyGemsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Reports Q1 Loss, Highlights Progress on TPI 287 for Brain Cancer

CNS Pharmaceuticals (NASDAQ: CNSP) reported a Q1 2025 net loss of $4.3 million, up from $3.5 million in the prior year period, as R&D spending increased to support data analysis for its Berubicin trial. The company remains focused on advancing TPI 287, a novel taxane with the potential to treat glioblastoma by crossing the blood-brain barrier. CNS has secured Orphan Drug Designation for TPI 287 and plans to initiate a Phase 2 study in recurrent GBM by late 2025. With $13.1 million in cash at quarter-end and an additional $5 million raised in May, the company expects to fund operations…

Spotlighting undiscovered companies with enormous upside potential.

Contact us: (512) 354-7000

TinyGemsBreaks